The COVID-19 crisis is tantamount to a trial by fire for India Pharma Inc. It has had to adapt, innovate and transform at a pace unprecedented to step up and meet the world’s huge expectations from the “Pharmacy of the World”.
And, the packaging is playing a crucial role in making the industry stronger and more resilient in the battle against the coronavirus pandemic. Now, with the roll-out of COVID-19 vaccines underway, its role has been amplified manifold. After all, it shares the responsibility of ensuring the safety and efficacy of vaccines, as well as other medicines and healthcare supplies until they reach those who need them the most.
Therefore, Express Pharma, continuing its role of facilitating progress in the life sciences industry and its allied sectors, is back with its Pharma Packaging and Labelling (PPL) Conclave, under the theme, “Decoding the pandemic effect”.
This year’s edition aims to support the pharma packaging fraternity as it works its way through a fresh set of challenges and opportunities in a rapidly shifting landscape.
Glimpses of past PPL Conclaves
For instance:
Denne historien er fra April 2021-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra April 2021-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Indian pharma industry: Urgent need for action in the manufacturing sector
Dr Ajay Babu Pazhayattil, President of cGMPWorld, offers invaluable insights from FDA Form 483 observations issued to Indian pharma facilities, shedding light on the industry's critical challenges today. His analysis provides immediate and practical plans to minimise regulatory compliance risks. These measures will help reinforce the Indian industry's commitment to supplying the much-needed lifesaving drug products for the regulated US market
Nutraceutical M&As: How strategic mergers are shaping the health and wellness market
The nutraceutical industry has seen a surge in M&A activity over the past three years as companies pursue strategic acquisitions to strengthen market positions, diversify offerings, and drive innovation. Sudhindran N, GM - Corporate Affairs, Nutrify Today explores key trends, motivations, notable deals, and future growth prospects shaping the industry
Harnessing data analytics to propel drug discovery and development in 2025
As the pharma landscape evolves, data analytics will be at the forefront of drug discovery and development, transforming traditional methods. By leveraging data-driven insights, companies can expedite R&D, optimise clinical trials, and personalise treatments, bringing life-saving therapies to market more efficiently, explains Biju Davis, SVP, Engineering, Model N
Strengthening our presence within APAC through increased penetration is a key focus
Aanchal Tomar, Executive Director, Asia Pacific, Lonza Capsules Health Ingredients speaks about Lonza Capsules Health Ingredients’ strategic growth, challenges, and sustainability initiatives in the APAC market, showcasing their innovative capsule solutions and health ingredients that cater to the region's diverse pharmaceutical and nutraceutical needs, in an interview with Express Pharma
Responsible Sourcing and Manufacturing: Growing towards a sustainable future with Lonza
In response to the establishment of environmental impact targets by the pharmaceutical industry, Lonza promotes responsible sourcing practices, sustainable manufacturing standards, and renewable energy utilisation showcasing that responsible manufacturing can assist our customers to reach their sustainability goals, highlights Christine Lebeault, Head of Applied Sustainability, Lonza Capsules and Health Ingredients
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation
Towards a healthier, more equitable and innovative Indian healthcare sector
Rishabh Bindlish, MD & Partner, Co-leads Boston Consulting Group Healthcare practice in India and Ayushi Shukla, Senior Knowledge Analyst, BCG highlight that the government needs to pave the way for a healthier, more equitable future with strategic investments and policy reforms
